Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Factors determining ultra-short-term survival and the commencement of active treatment in high-grade serous ovarian cancer: a case comparison study

Fig. 3

Sankey diagrams demonstrating the difference in treatment regimens received by each group, including (a) the entire cohort (excluding 11 of the 208 patients for whom treatment was not known). b USTS cases, of whom only 10/28 (36%) commenced treatment, in contrast to (c) comparison patients. Of whom 131/134(98%) commenced active therapy. Of those that underwent PDS, only four did not receive adjuvant chemotherapy. Of the 127 patients who underwent chemotherapy, 103 (81%) completed all 6 cycles

Back to article page